Parkinson's disease presents a significant public health challenge, costing the US $52 billion yearly. Technology, particularly device-aided care, offers avenues for improvement, aiding in measuring progression, assessing treatment efficacy, and providing interventions. Research seeks digital outcome measures to supplement clinician-rated scales, facing regulatory and validation hurdles. Clinical adoption lags due to lacking business models, implementation guidance, and reimbursement issues. Movement disorder specialists and specialized centers show more adoption due to familiarity and quality focus, influenced by institutional branding and non-financial incentives. Broader uptake requires addressing reimbursement structures and establishing clear integration guidelines. Despite promise, overcoming regulatory, financial, and practical barriers is crucial for widespread implementation in Parkinson's disease management.
Parkinson's disease presents a significant public health challenge, costing the US $52 billion yearly. Technology, particularly device-aided care, offers avenues for improvement, aiding in measuring progression, assessing treatment efficacy, and providing interventions. Research seeks digital outcome measures to supplement clinician-rated scales, facing regulatory and validation hurdles. Clinical adoption lags due to lacking business models, implementation guidance, and reimbursement issues. Movement disorder specialists and specialized centers show more adoption due to familiarity and quality focus, influenced by institutional branding and non-financial incentives. Broader uptake requires addressing reimbursement structures and establishing clear integration guidelines. Despite promise, overcoming regulatory, financial, and practical barriers is crucial for widespread implementation in Parkinson's disease management.